2 Best Cannabis Stocks to Buy in August

If you were wondering: No, the marijuana industry hasn't lost its allure. Although the Horizons Marijuana Life Sciences ETF fell 36% in the past year, some pot stocks have reported impressive sales. With national elections on the horizon and marijuana legalization initiatives on the ballot in few U.S. states, investors are optimistic about the industry's room to grow. Medical cannabis is already legal across Canada, in 33 U.S. states, and the District of Columbia. The market should expand even more as marijuana-related therapies offer patients benefits that conventional therapies have failed to provide.

Investors are rightfully hesitant to bet on U.S. pot stocks. Because marijuana is still illegal at the federal level in the U.S., Canadian companies tend to be the safer choice for curious stock pickers. But a few domestic companies, like Green Thumb Industries (OTC: GTBIF) and Curaleaf (OTC: CURLF), have outperformed their counterparts to the north this year. While Aurora Cannabis and Canopy Growth have fallen by 60% and 20% this year, respectively, Green Thumb and Curaleaf have gained 57% and 42%. The market, tracked by the SPDR S&P 500 ETF, has gained about 5%. Let's dive deeper into these two U.S. cannabis stocks.

Continue reading

Source Fool.com